The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cardiac safety of a granisetron transdermal system in the treatment of chemotherapy-induced nausea and vomiting.
J. D. Howell
Employment or Leadership Position - Prostrakan
Stock Ownership - Prostrakan
J. Mason
Consultant or Advisory Role - Prostrakan (U)
B. O'Mahony
Employment or Leadership Position - Prostrakan
P. Donachie
Employment or Leadership Position - Prostrakan